- Home
- VYNE vs AMPG Comparison
VYNE vs AMPG Comparison
Compare VYNE & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- AMPG
- Stock Information
- Founded
- VYNE 2003
- AMPG 2002
- Country
- VYNE United States
- AMPG United States
- Employees
- VYNE N/A
- AMPG N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- AMPG Telecommunications Equipment
- Sector
- VYNE Health Care
- AMPG Telecommunications
- Exchange
- VYNE Nasdaq
- AMPG Nasdaq
- Market Cap
- VYNE 35.7M
- AMPG 34.2M
- IPO Year
- VYNE 2018
- AMPG N/A
- Fundamental
- Price
- VYNE $1.31
- AMPG $1.84
- Analyst Decision
- VYNE Strong Buy
- AMPG Strong Buy
- Analyst Count
- VYNE 2
- AMPG 1
- Target Price
- VYNE $6.25
- AMPG $5.00
- AVG Volume (30 Days)
- VYNE 223.6K
- AMPG 326.0K
- Earning Date
- VYNE 05-08-2025
- AMPG 05-27-2025
- Dividend Yield
- VYNE N/A
- AMPG N/A
- EPS Growth
- VYNE N/A
- AMPG N/A
- EPS
- VYNE N/A
- AMPG N/A
- Revenue
- VYNE $605,000.00
- AMPG $9,508,372.00
- Revenue This Year
- VYNE N/A
- AMPG $82.37
- Revenue Next Year
- VYNE N/A
- AMPG $76.47
- P/E Ratio
- VYNE N/A
- AMPG N/A
- Revenue Growth
- VYNE 18.16
- AMPG N/A
- 52 Week Low
- VYNE $1.27
- AMPG $0.64
- 52 Week High
- VYNE $4.30
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- VYNE 33.79
- AMPG 57.36
- Support Level
- VYNE $1.27
- AMPG $1.70
- Resistance Level
- VYNE $1.41
- AMPG $1.94
- Average True Range (ATR)
- VYNE 0.11
- AMPG 0.16
- MACD
- VYNE -0.02
- AMPG 0.01
- Stochastic Oscillator
- VYNE 0.00
- AMPG 80.89
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.